Overview
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.
Monitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
Clinical Trials
6 trials linked to this intervention
Recent Trials
Treatment of Binge Eating in Obese Patients in Primary Care
Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients
Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes
A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.
Related Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Specialists
Providers who commonly manage this intervention
Family Medicine — Obesity Medicine
NUCC 207QB0002XInternal Medicine — Obesity Medicine
NUCC 207RB0002XInternal Medicine — Endocrinology, Diabetes & Metabolism
NUCC 207RE0101XHealth Goals
Goals connected through associated conditions
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Sibutramine (substance)
- SNOMED CT
- 386838007
- UMLS CUI
- C0074493
- RxNorm CUI
- 36514
Clinical Data
This intervention maps to 9 entities in the Ltrl knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.